Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous Abstract"Human exposure risk to semivolatile organic compounds via soil in automobile workshops in Awka, South Eastern, Nigeria"    Next AbstractImmunolocalization of Receptor and Chemoreceptor Modules in the Sheep Vomeronasal Organ »

Thorax


Title:Non-invasive phenotyping using exhaled volatile organic compounds in asthma
Author(s):Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ;
Address:"Respiratory Research Group, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"
Journal Title:Thorax
Year:2011
Volume:20110711
Issue:9
Page Number:804 - 809
DOI: 10.1136/thx.2010.156695
ISSN/ISBN:1468-3296 (Electronic) 0040-6376 (Linking)
Abstract:"BACKGROUND: Breath volatile organic compounds (VOCs) may be useful for asthma diagnosis and phenotyping, identifying patients who could benefit from personalised therapeutic strategies. The authors aimed to identify specific patterns of breath VOCs in patients with asthma and in clinically relevant disease phenotypes. METHODS: Breath samples were analysed by gas chromatography-mass spectrometry. The Asthma Control Questionnaire was completed, together with lung function and induced sputum cell counts. Breath data were reduced to principal components, and these principal components were used in multiple logistic regression to identify discriminatory models for diagnosis, sputum inflammatory cell profile and asthma control. RESULTS: The authors recruited 35 patients with asthma and 23 matched controls. A model derived from 15 VOCs classified patients with asthma with an accuracy of 86%, and positive and negative predictive values of 0.85 and 0.89, respectively. Models also classified patients with asthma based on the following phenotypes: sputum (obtained in 18 patients with asthma) eosinophilia >/=2% area under the receiver operating characteristics (AUROC) curve 0.98, neutrophilia >/=40% AUROC 0.90 and uncontrolled asthma (Asthma Control Questionnaire >/=1) AUROC 0.96. CONCLUSIONS: Detection of characteristic breath VOC profiles could classify patients with asthma versus controls, and clinically relevant disease phenotypes based on sputum inflammatory profile and asthma control. Prospective validation of these models may lead to clinical application of non-invasive breath profiling in asthma"
Keywords:Asthma/*diagnosis/metabolism Breath Tests/*methods Disease Progression *Exhalation Female Follow-Up Studies Humans Male Middle Aged Organic Chemicals/*analysis Phenotype Reproducibility of Results Sensitivity and Specificity Smoking/*metabolism Volatiliza;
Notes:"MedlineIbrahim, Baharudin Basanta, Maria Cadden, Paul Singh, Dave Douce, David Woodcock, Ashley Fowler, Stephen J eng England 2011/07/14 Thorax. 2011 Sep; 66(9):804-9. doi: 10.1136/thx.2010.156695. Epub 2011 Jul 11"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-09-2024